• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number UNK432
Device Problem Occlusion Within Device (1423)
Patient Problems Bradycardia (1751); Myocardial Infarction (1969); Reocclusion (1985); Chest Tightness/Pressure (2463)
Event Date 08/31/2015
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.The device was not received for analysis.The batch number is unknown and the manufacturing records for the complaint device could not be reviewed.The most probable root cause was unable to be determined.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2015-06594.(b)(4) clinical study.It was reported that myocardial infarction (mi) and in-stent restenosis (isr) occurred.In (b)(6) 2005, a 2.5x20mm taxus stent was implanted in the distal left anterior descending (lad) artery.In (b)(6) 2014, the patient presented with unstable angina and a 3.00x20.00mm promus element plus stent was implanted in proximal right coronary artery (rca).In (b)(6) 2015, the patient presented due to chest tightness.Patient's electrocardiogram (ecg) shows a normal sinus rhythm, q wave in lead and no other st-t wave changes, and the final impression was sinus bradycardia.Patient's coronary angiography revealed 70% apical stenosis within previously placed 2.5x20mm taxus stent in distal lad and 90% isr of the previously placed 3.0x20mm promus element plus stent in the proximal rca.The 90% stenosis in the previously placed 3.0x20mm promus element plus stent in proximal rca was treated with placement of a 3.00x20.00mm promus drug eluting stent.Following post-dilatation, residual stenosis was 0%.No treatment was done for the isr of the previously placed taxus stent in distal lad.In (b)(6) 2015, the event was considered as resolved and the patient was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5112115
MDR Text Key27051756
Report Number2134265-2015-06587
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Report Date 09/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/29/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK432
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/02/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age72 YR
-
-